**No Level 4 CDC Travel Health Notice appears imminent by year-end, supporting the 75% market-implied probability.** CDC Level 4 notices, which advise avoiding all travel due to extreme health risks with no effective precautions, remain unused as of mid-June 2026. Current notices top out at Level 2 for circulating poliovirus (updated March 2026 to include Laos and Namibia) and select Level 1 alerts for dengue, chikungunya, hepatitis A, and global measles. These reflect ongoing but contained transmission patterns monitored by CDC surveillance, without the uncontrolled outbreaks or novel pathogens that historically trigger Level 4 status, such as peak COVID-19 surges. No recent model runs, case thresholds, or official CDC/NOAA-style escalations point to conditions that would meet Level 4 criteria—extreme risk without mitigation options—before December 31. Traders appear to weigh the low baseline likelihood of rapid escalation against routine seasonal and endemic activity, with upcoming surveillance updates unlikely to shift this assessment absent a major emergence.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado¿Los CDC emiten una advertencia de Nivel 4 antes del 31 de diciembre?
¿Los CDC emiten una advertencia de Nivel 4 antes del 31 de diciembre?
Sí
$71,968 Vol.
$71,968 Vol.
31 dic 2026
Sí
$71,968 Vol.
$71,968 Vol.
31 dic 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.**No Level 4 CDC Travel Health Notice appears imminent by year-end, supporting the 75% market-implied probability.**
CDC Level 4 notices, which advise avoiding all travel due to extreme health risks with no effective precautions, remain unused as of mid-June 2026. Current notices top out at Level 2 for circulating poliovirus (updated March 2026 to include Laos and Namibia) and select Level 1 alerts for dengue, chikungunya, hepatitis A, and global measles. These reflect ongoing but contained transmission patterns monitored by CDC surveillance, without the uncontrolled outbreaks or novel pathogens that historically trigger Level 4 status, such as peak COVID-19 surges.
No recent model runs, case thresholds, or official CDC/NOAA-style escalations point to conditions that would meet Level 4 criteria—extreme risk without mitigation options—before December 31. Traders appear to weigh the low baseline likelihood of rapid escalation against routine seasonal and endemic activity, with upcoming surveillance updates unlikely to shift this assessment absent a major emergence.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Mercado abierto: Jan 19, 2026, 3:15 PM ET
Volumen
$71,968Fecha de finalización
31 dic 2026Mercado abierto
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.**No Level 4 CDC Travel Health Notice appears imminent by year-end, supporting the 75% market-implied probability.**
CDC Level 4 notices, which advise avoiding all travel due to extreme health risks with no effective precautions, remain unused as of mid-June 2026. Current notices top out at Level 2 for circulating poliovirus (updated March 2026 to include Laos and Namibia) and select Level 1 alerts for dengue, chikungunya, hepatitis A, and global measles. These reflect ongoing but contained transmission patterns monitored by CDC surveillance, without the uncontrolled outbreaks or novel pathogens that historically trigger Level 4 status, such as peak COVID-19 surges.
No recent model runs, case thresholds, or official CDC/NOAA-style escalations point to conditions that would meet Level 4 criteria—extreme risk without mitigation options—before December 31. Traders appear to weigh the low baseline likelihood of rapid escalation against routine seasonal and endemic activity, with upcoming surveillance updates unlikely to shift this assessment absent a major emergence.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volumen
$71,968Fecha de finalización
31 dic 2026Mercado abierto
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...**No Level 4 CDC Travel Health Notice appears imminent by year-end, supporting the 75% market-implied probability.** CDC Level 4 notices, which advise avoiding all travel due to extreme health risks with no effective precautions, remain unused as of mid-June 2026. Current notices top out at Level 2 for circulating poliovirus (updated March 2026 to include Laos and Namibia) and select Level 1 alerts for dengue, chikungunya, hepatitis A, and global measles. These reflect ongoing but contained transmission patterns monitored by CDC surveillance, without the uncontrolled outbreaks or novel pathogens that historically trigger Level 4 status, such as peak COVID-19 surges. No recent model runs, case thresholds, or official CDC/NOAA-style escalations point to conditions that would meet Level 4 criteria—extreme risk without mitigation options—before December 31. Traders appear to weigh the low baseline likelihood of rapid escalation against routine seasonal and endemic activity, with upcoming surveillance updates unlikely to shift this assessment absent a major emergence.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes